In8bio Current Ratio Growth & History (INAB)

In8bio's current ratio was 8.82 for fiscal 2025.

View full In8bio company overview

In8bio annual current ratio history

In8bio annual current ratio

Fiscal yearPeriod endedCurrent ratioChangeGrowth
20252025-12-318.824.74+116.19%
20242024-12-314.08−0.49−10.65%
20232023-12-314.570.75+19.56%
20222022-12-313.82−13.46−77.90%
20212021-12-3117.2810.22+144.93%
20202020-12-317.05

In8bio current ratio trends

Over the last five fiscal years, In8bio's current ratio increased from 7.05 to 8.82, a change of 1.77. The latest reported quarter, Q2 2026, shows 8.21.

About the metric

What the current ratio means

The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.

Calculation and source

How the current ratio is calculated

TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review In8bio source filings ↗

Community posts

It’s quiet here.

No posts about INAB yet. Start the conversation.

Write the first post